55 related articles for article (PubMed ID: 14748258)
1. Susceptibility of group A beta-hemolytic streptococci in the lower St Lawrence region, Quebec.
Desrosiers A; Dolcé P; Jutras P; Jetté LP
Can J Infect Dis; 1999 Jul; 10(4):279-85. PubMed ID: 22346387
[TBL] [Abstract][Full Text] [Related]
2. Macrolide - induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin.
Westphal JF
Br J Clin Pharmacol; 2000 Oct; 50(4):285-95. PubMed ID: 11012550
[No Abstract] [Full Text] [Related]
3. Macrolide resistance among Streptococcus agalactiae during COVID-19 public health emergency in Brazil.
Barros RR; Barros CC; Kegele FCO; Francisca da S N Soares M; de Paula GR
Braz J Microbiol; 2024 Apr; ():. PubMed ID: 38687418
[TBL] [Abstract][Full Text] [Related]
4. Immunotechniques for the Group Determination of Macrolide Antibiotics Traces in the Environment Using a Volume-Mediated Sensitivity Enhancement Strategy.
Burkin MA; Tevyashova AN; Bychkova EN; Melekhin AO; Galvidis IA
Biosensors (Basel); 2023 Oct; 13(10):. PubMed ID: 37887114
[TBL] [Abstract][Full Text] [Related]
5. Clinical implications of macrolide resistance in community-acquired respiratory tract infections.
Hoban DJ; Zhanel GG
Expert Rev Anti Infect Ther; 2006 Dec; 4(6):973-80. PubMed ID: 17181414
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic resistance: relationship to persistence of group A streptococci in the upper respiratory tract.
Gerber MA
Pediatrics; 1996 Jun; 97(6 Pt 2):971-5. PubMed ID: 8637784
[TBL] [Abstract][Full Text] [Related]
7. [Investigation of erythromycin resistance and resistance phenotypes in group A beta hemolytic streptococci].
Kaya EG; Yücel M; Karakoç AE
Mikrobiyol Bul; 2006 Jul; 40(3):161-8. PubMed ID: 17001844
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary.
Gattringer R; Sauermann R; Lagler H; Stich K; Buxbaum A; Graninger W; Georgopoulos A
Int J Antimicrob Agents; 2004 Sep; 24(3):290-3. PubMed ID: 15325435
[TBL] [Abstract][Full Text] [Related]
9. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes.
Mason EO; Wald ER; Bradley JS; Barson WJ; Kaplan SL;
Pediatr Infect Dis J; 2003 Jul; 22(7):623-7. PubMed ID: 12867838
[TBL] [Abstract][Full Text] [Related]
10. [Macrolide resistance phenotypes and genotypes in group G streptococci].
Açikgöz ZC; Göçer S; Almayanlar E
Mikrobiyol Bul; 2003; 37(2-3):117-24. PubMed ID: 14593892
[TBL] [Abstract][Full Text] [Related]
11. [Streptococcus pyogenes: penicillin and erythromycin susceptibility in the cities of Neuquen and Cipolletti].
Soriano SV; Brasili S; Saiz M; Carranza C; Vidal P; Calderón J; Lopardo HA
Medicina (B Aires); 2000; 60(4):487-90. PubMed ID: 11188957
[TBL] [Abstract][Full Text] [Related]
12. [Macrolide antibiotic resistance rates and phenotypes of group A beta hemolytic streptococci isolated between the years 1999-2000 and 2001-2002].
Senses Z; Baysallar M; Gür D; Doğanci L
Mikrobiyol Bul; 2003 Oct; 37(4):225-34. PubMed ID: 14748258
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
